Psyadon Pharmaceuticals, Inc.

Ecopipam

Ecopipam is a selective antagonist of the D1 dopamine receptor. Its safety profile has been studied in over 1000 people.

Psyadon Pharmaceuticals is studying this drug for its ability to ameliorate multiple central nervous system diseases.